CSIMarket
 


Conformis inc   (CFMS)
Other Ticker:  
 
 

CFMS's Capital Expenditures Growth by Quarter and Year

Conformis Inc 's Capital Expenditures results by quarter and year




CFMS Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.32 0.47 0.25
III Quarter September - 0.61 0.87 0.41
II Quarter June 0.31 0.30 0.60 1.11
I Quarter March 0.91 0.69 0.37 1.48
FY   1.22 1.92 2.31 3.25



CFMS Capital Expenditures second quarter 2023 Y/Y Growth Comment
Conformis inc reported Capital Expenditures growth of 2.67% year on year in the second quarter 2023, to $ 0.31 millions, this is lower than Conformis Inc 's recent average Capital Expenditures growth of 6.98%.

Looking into second quarter 2023 results within Medical Equipment & Supplies industry 69 other companies have achieved higher Capital Expenditures growth. While Conformis Inc ' s Capital Expenditures increase of 2.67% ranks overall at the positon no. 1714 in the second quarter 2023.




CFMS Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -31.91 % 88 % -69.51 %
III Quarter September - -29.89 % 112.2 % -48.75 %
II Quarter June 2.67 % -50 % -45.95 % 105.56 %
I Quarter March 31.88 % 86.49 % -75 % 94.74 %
FY   - -16.88 % -28.92 % 11.3 %

Financial Statements
Conformis Inc 's second quarter 2023 Capital Expenditures $ 0.31 millions CFMS's Income Statement
Conformis Inc 's second quarter 2022 Capital Expenditures $ 0.30 millions Quarterly CFMS's Income Statement
New: More CFMS's historic Capital Expenditures Growth >>


CFMS Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -47.54 % -45.98 % -39.02 %
III Quarter September - 103.33 % 45 % -63.06 %
II Quarter June -66.15 % -56.52 % 62.16 % -25 %
I Quarter March 184.38 % 46.81 % 48 % 80.49 %
FY (Year on Year)   - -16.88 % -28.92 % 11.3 %




Capital Expenditures second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #70
Healthcare Sector #253
Overall #1714

Capital Expenditures Y/Y Growth Statistics
High Average Low
204.93 % 6.98 % -75.29 %
(Sep 30 2016)   (Mar 31 2021)
Capital Expenditures second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #70
Healthcare Sector #253
Overall #1714
Capital Expenditures Y/Y Growth Statistics
High Average Low
204.93 % 6.98 % -75.29 %
(Sep 30 2016)   (Mar 31 2021)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Conformis Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
237.56 % 18.92 % -73.01 %
(Mar 31 2016)  


CFMS's II. Quarter Q/Q Capital Expenditures Comment
In the II. Quarter 2023 Conformis Inc reported fall in Capital Expenditures from the previous quarter by -66.15% to $ 0.31 millions, from $ 0.91 millions achived a quarter before.

When you evaluate recent slump at the II. Quarter, you must take into consideration, that commonly II. Quarter Capital Expenditures emerge weaker then in the first quarter

Within Medical Equipment & Supplies industry 30 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Conformis Inc 's Capital Expenditures growth quarter on quarter, overall rank is 835.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #95
Overall #835
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #95
Overall #835
Capital Expenditures Q/Q Growth Statistics
High Average Low
237.56 % 18.92 % -73.01 %
(Mar 31 2016)  


CFMS's II. Quarter Q/Q Capital Expenditures Comment
In the II. Quarter 2023 Conformis Inc disclosed fall in Capital Expenditures sequentially by -66.15% to $ 0.31 millions, from $ 0.91 millions released in the previous quarter.

When you look into recent shortcoming in the II. Quarter 2023, you should assume, that frequently II. Quarter performance emerge weaker then in the quarter before, Leah Martin, an industry researcher added.

Within Medical Equipment & Supplies industry 30 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Conformis Inc 's Capital Expenditures growth quarter on quarter, overall rank is 835.


Conformis Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Capital Expenditures 12 Months Ending $ 2.14 $ 2.13 $ 1.92 $ 2.07 $ 2.33
Y / Y Capital Expenditures Growth (TTM) -7.99 % -18.8 % -16.61 % -0.72 % 43.59 %
Year on Year Capital Expenditures Growth Overall Ranking # 164 # 883 # 1613 # 1151 # 865
Seqeuential Capital Expenditures Change (TTM) 0.47 % 11.21 % -7.12 % -11.34 % -11.34 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1686 # 1007 # 1055 # 1468 # 2110




Cumulative Capital Expenditures growth Comment
Conformis Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Mar 31 2023. If the fiscal year would end in Jun 30 2023, Conformis Inc 's annual Capital Expenditures fall would be -7.99% year on year to $2 millions.

Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 164, from total ranking in previous quarter at 883.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
43.59 %
-12.68 %
-61.53 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 76
Healthcare Sector # 19
Overall # 164

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
43.59 %
-12.68 %
-61.53 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 76
Sector # 252
S&P 500 # 1686
Cumulative Capital Expenditures growth Comment
Conformis Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Mar 31 2023. If the fiscal year would end in Jun 30 2023, Conformis Inc 's annual Capital Expenditures drop would be -7.99% year on year to $2 millions.

Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 164, from total ranking in previous quarter at 883.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
43.59 %
-12.68 %
-61.53 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 76
Healthcare Sector # 19
Overall # 164

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
43.59 %
-12.68 %
-61.53 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 76
Sector # 252
S&P 500 # 1686




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
CFMS's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for CFMS's Competitors
Capital Expenditures Growth for Conformis Inc 's Suppliers
Capital Expenditures Growth for CFMS's Customers

You may also want to know
CFMS's Annual Growth Rates CFMS's Profitability Ratios CFMS's Asset Turnover Ratio CFMS's Dividend Growth
CFMS's Roe CFMS's Valuation Ratios CFMS's Financial Strength Ratios CFMS's Dividend Payout Ratio
CFMS's Roa CFMS's Inventory Turnover Ratio CFMS's Growth Rates CFMS's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Jun 30 2023
Nuvasive Inc4.19%$ 4.195 millions
Conformis inc 3.36%$ 3.356 millions
Cytek Biosciences Inc 3.01%$ 3.012 millions
Deciphera Pharmaceuticals Inc 2.09%$ 2.091 millions
Motus Gi Holdings Inc 2.08%$ 2.083 millions
Sangamo Therapeutics Inc 1.74%$ 1.745 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com